Oruka Therapeutics, Inc.
Shares Outstanding
| Period | Shares Outstanding |
|---|---|
| Mar 2017 | 9.1M |
| Mar 2017 | 9.2M |
| May 2017 | 9.2M |
| Jun 2017 | 10.1M |
| Jul 2017 | 11.8M |
| Sep 2017 | 11.8M |
| Nov 2017 | 11.8M |
| Dec 2017 | 11.8M |
| Mar 2018 | 13.9M |
| Mar 2018 | 13.9M |
| May 2018 | 13.9M |
| Jun 2018 | 13.9M |
| Aug 2018 | 13.9M |
| Sep 2018 | 13.9M |
| Nov 2018 | 13.9M |
| Dec 2018 | 773.6K |
| Feb 2019 | 18.4M |
| Mar 2019 | 1.1M |
| May 2019 | 1.1M |
| Jun 2019 | 1.5M |
| Jul 2019 | 1.5M |
| Sep 2019 | 1.6M |
| Nov 2019 | 1.6M |
| Dec 2019 | 1.6M |
| Feb 2020 | 1.6M |
| Mar 2020 | 1.6M |
| May 2020 | 1.6M |
| Jun 2020 | 2.3M |
| Jul 2020 | 5.9M |
| Sep 2020 | 9.3M |
| Oct 2020 | 9.3M |
| Dec 2020 | 9.5M |
| Mar 2021 | 14.4M |
| Mar 2021 | 14.4M |
| May 2021 | 14.4M |
| Jun 2021 | 14.4M |
| Aug 2021 | 14.4M |
| Sep 2021 | 14.4M |
| Nov 2021 | 14.4M |
| Dec 2021 | 14.4M |
| Mar 2022 | 14.4M |
| Mar 2022 | 14.4M |
| Apr 2022 | 14.4M |
| Jun 2022 | 14.4M |
| Aug 2022 | 14.4M |
| Sep 2022 | 14.4M |
| Oct 2022 | 14.4M |
| Dec 2022 | 14.4M |
| Feb 2023 | 14.4M |
| Mar 2023 | 14.4M |
| Apr 2023 | 14.4M |
| Jun 2023 | 14.4M |
| Jul 2023 | 14.4M |
| Sep 2023 | 14.4M |
| Oct 2023 | 14.4M |
| Dec 2023 | 14.5M |
| Jan 2024 | 14.5M |
| Feb 2024 | 3.2M |
| Mar 2024 | 14.5M |
| Apr 2024 | 14.5M |
| Jun 2024 | 3.2M |
| Jul 2024 | 14.5M |
| Sep 2024 | 15.0M |
| Oct 2024 | 35.0M |
| Dec 2024 | 37.4M |
| Feb 2025 | 37.4M |
| Mar 2025 | 41.7M |
| Apr 2025 | 37.4M |
| Jun 2025 | 42.1M |
| Jul 2025 | 37.5M |
| Sep 2025 | 48.4M |
| Oct 2025 | 48.4M |
| Dec 2025 | 48.7M |
| Feb 2026 | 49.5M |
| Mar 2026 | 50.2M |
| Apr 2026 | 60.3M |
| Jun 2026 | 61.1M |
| Jul 2026 | 66.2M |